PHARMING (PHARM ) | WebDisclosure

Basculer en Français

8633	Companies
144803	Keywords
80463	Articles
77452	Press releases

Home
Companies
PHARMING

BRIEF

published on 04/03/2025 at 17:13, 26 days 17 hours ago

Pharming Group NV: Buy Recommendation Boosted by Optimistic Outlook

Acquisition Clinical Trials Investment Pharming Group Biotech Growth
BRIEF

published on 04/03/2025 at 17:13, 26 days 17 hours ago

Pharming Group NV : recommandation d'achat renforcée par des perspectives optimistes

Acquisition Investissement Essais Cliniques Groupe Pharmaceutique Croissance De La Biotechnologie
PRESS RELEASE

published on 04/03/2025 at 17:08, 26 days 17 hours ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Pharming Group NV (NL0010391025) to EUR 2.30 target price. Second phase II trial of leniolisib for PIDs announced, acquisition of Abliva completed. Revenue potential >USD1bn

First Berlin Equity Research Leniolisib Pharming Group NV Abliva Acquisition Blockbuster Potential
BRIEF

published on 10/29/2024 at 14:57, 6 months ago

Pharming Group NV: Promising Outlook Amid Executive Change

Sales Growth Executive Change Profitability Outlook Leniolisib Pharming Group
BRIEF

published on 10/29/2024 at 14:57, 6 months ago

Pharming Group NV : Perspectives prometteuses malgré le changement de direction

Changement De Direction Croissance Des Ventes Leniolisib Groupe Pharmaceutique Perspectives De Rentabilité
PRESS RELEASE

published on 10/29/2024 at 14:52, 6 months ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research raises price target for Pharming Group NV after Q3/24 results. CEO not seeking reappointment unrelated to business. Market undervaluing APDS drug sales potential. Expect significant revenue growth

Revenue Growth First Berlin Equity Research Pharming Group NV Q3/24 Results APDS Drug
BRIEF

published on 08/26/2024 at 16:01, 8 months 3 days ago

First Berlin Equity Research Reiterates 'Buy' Rating for Pharming Group NV

Price Target Equity Research Patient Growth Pharming Leniolisib
BRIEF

published on 08/26/2024 at 16:01, 8 months 3 days ago

First Berlin Equity Research réitère sa note « Acheter » pour Pharming Group NV

Objectif De Prix Recherche Sur Les Actions Pharmaceutique Leniolisib Croissance Des Patients
PRESS RELEASE

published on 08/26/2024 at 15:56, 8 months 3 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Pharming Group NV to Buy with a target price of €1.60. Q2/24 showed strong performance with revenue up 35% yoy and 33% qoq

Revenue First Berlin Equity Research Buy Recommendation Q2/24 Pharming Group NV
PRESS RELEASE

published on 08/09/2023 at 14:46, 1 year 8 months ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 04/30/2025 at 08:00, 2 hours 32 minutes ago

Argo Blockchain PLC Announces Financial Update and Listing Suspension Request
Published on 04/30/2025 at 03:05, 7 hours 27 minutes ago

Quarterly Activities and Cashflow Report
Published on 04/30/2025 at 01:25, 9 hours 7 minutes ago

UniDoc Provides Update on Marketing Engagement
Published on 04/30/2025 at 01:20, 9 hours 12 minutes ago

Electric Metals (USA) Limited Closes $3.0 Million Non-Brokered Private Placement Led by Eric Sprott and Crescat Capital
Published on 04/29/2025 at 23:30, 11 hours 2 minutes ago

Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants

View all ACCESSWIRE

EQS Group

Published on 04/30/2025 at 10:11, 20 minutes ago

swissnet Group launches major new project with leading hotel chain in the DACH region to modernize digital infrastructure at more than 40 locations, with a total potential value of over € 3.5 million
Published on 04/30/2025 at 10:10, 22 minutes ago

Hoffmann & Partner and High Tech Services Join Forces to Build the Leading Financial Services Platform for Life Sciences Companies in the DACH Region
Published on 04/30/2025 at 10:06, 26 minutes ago

DF Group enters blood plasma market
Published on 04/30/2025 at 10:00, 32 minutes ago

Sto SE & Co. KGaA: Difficult market conditions burden the 2024 business development
Published on 04/30/2025 at 10:00, 32 minutes ago

Asklepios Group: Publication of Asklepios CSRD Report 2024

Les Echos

Published on 04/30/2025 at 08:30, 2 hours 2 minutes ago

Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:13, 15 hours 19 minutes ago

Rapport Financier Annuel - 31/12/2024
Published on 04/29/2025 at 19:02, 15 hours 29 minutes ago

LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 16 hours 10 minutes ago

BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 16 hours 20 minutes ago

250429 BENETEAU Avis de mise à disposition de documents

View all LES ECHOS COMFI WIRE